Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Corporate Vice President, Business Development, Astellas Pharma, Inc.
Mr. Jun Kono has been in his current position since April 1st 2016, responsible for global business development at Astellas. His duty covers shaping Astellas’ business, pipeline and product portfolio through the management and execution of transaction initiatives, as well as subsequent alliance management with strategic collaboration partners. Mr. Kono has served various leadership roles at Astellas, most recently, was responsible as Vice President, Corporate Strategy and Communications for EMEA Operations, based in the UK. Prior to that, he has served as Vice President, Executive Office in global headquarters, and held other positions in strategic planning and business development with increasing responsibility within Astellas.
His key business development engagement includes the merger and subsequent integration project with Fujisawa, to create Astellas in 2005, and acquisition of oncology focused biotech companies, such as OSI Pharmaceuticals in 2010 and Ganymed Pharmaceuticals in 2016.
Mr. Kono received degree of Bachelor of Arts, Business Economics from Tohoku University, and Master of Business Administration with honors from The University of Chicago Booth School of Business.